122 related articles for article (PubMed ID: 6827531)
21. Folate analogues altered in the C9--N10 bridge region. 14. 11-Oxahomofolic acid, a potential antitumor agent.
Nair MG; Saunders C; Chen SY; Kisliuk RL; Gaumont Y
J Med Chem; 1980 Jan; 23(1):59-65. PubMed ID: 6767031
[No Abstract] [Full Text] [Related]
22. Design, synthesis and biological evaluation of novel 6-substituted pyrrolo [3,2-d] pyrimidine analogues as antifolate antitumor agents.
Tian C; Wang M; Han Z; Fang F; Zhang Z; Wang X; Liu J
Eur J Med Chem; 2017 Sep; 138():630-643. PubMed ID: 28711701
[TBL] [Abstract][Full Text] [Related]
23. Quinazoline antifolate thymidylate synthase inhibitors: replacement of glutamic acid in the C2-methyl series.
Marsham PR; Jackman AL; Barker AJ; Boyle FT; Pegg SJ; Wardleworth JM; Kimbell R; O'Connor BM; Calvert AH; Hughes LR
J Med Chem; 1995 Mar; 38(6):994-1004. PubMed ID: 7699716
[TBL] [Abstract][Full Text] [Related]
24. Quinazoline antifolate thymidylate synthase inhibitors: gamma-linked L-D, D-D, and D-L dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
Bavetsias V; Jackman AL; Kimbell R; Gibson W; Boyle FT; Bisset GM
J Med Chem; 1996 Jan; 39(1):73-85. PubMed ID: 8568829
[TBL] [Abstract][Full Text] [Related]
25. Quinazoline antifolates inhibiting thymidylate synthase: 2-desamino derivatives with enhanced solubility and potency.
Jones TR; Thornton TJ; Flinn A; Jackman AL; Newell DR; Calvert AH
J Med Chem; 1989 Apr; 32(4):847-52. PubMed ID: 2704030
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of novel antifolate analogs as potential anticancer treatment.
Stoicescu DF; Rotaru M
Anticancer Agents Med Chem; 2013 Feb; 13(2):364-72. PubMed ID: 23157590
[TBL] [Abstract][Full Text] [Related]
27. Quinazoline antifolates inhibiting thymidylate synthase: 4-thio-substituted analogues.
Thornton TJ; Jones TR; Jackman AL; Flinn A; O'Connor BM; Warner P; Calvert AH
J Med Chem; 1991 Mar; 34(3):978-84. PubMed ID: 2002476
[TBL] [Abstract][Full Text] [Related]
28. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases.
Gangjee A; Vasudevan A; Queener SF; Kisliuk RL
J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of aza homologues of folic acid.
Martinelli JE; Chaykovsky M; Kisliuk RL; Gaumont Y
J Med Chem; 1979 Jul; 22(7):874-7. PubMed ID: 109617
[TBL] [Abstract][Full Text] [Related]
30. The inhibition of dihydrofolate reductase by folate analogues: structural requirements for slow- and tight-binding inhibition.
Williams JW; Duggleby RG; Cutler R; Morrison JF
Biochem Pharmacol; 1980 Feb; 29(4):589-95. PubMed ID: 7370052
[No Abstract] [Full Text] [Related]
31. Folate analogues altered in the C9-N10 bridge region. 10-Oxafolic acid and 10-oxaaminopterin.
Nair MG; Campbell PT
J Med Chem; 1976 Jun; 19(6):825-9. PubMed ID: 820858
[TBL] [Abstract][Full Text] [Related]
32. Folate analogues. 22. Synthesis and biological evaluation of two analogues of dihydrofolic acid possessing a 7,8-dihydro-8-oxapterin ring system.
Nair MG; Salter OC; Kisliuk RL; Gaumont Y; North G
J Med Chem; 1983 Aug; 26(8):1164-8. PubMed ID: 6410065
[TBL] [Abstract][Full Text] [Related]
33. Novel 2-amino-4-oxo-5-arylthio-substituted-pyrrolo[2,3-d]pyrimidines as nonclassical antifolate inhibitors of thymidylate synthase.
Gangjee A; Jain HD; Kisliuk RL
Bioorg Med Chem Lett; 2005 May; 15(9):2225-30. PubMed ID: 15837298
[TBL] [Abstract][Full Text] [Related]
34. Thymidylate synthetase from Diplococcus pneumoniae, properties and inhibition by folate analogs.
McCuen RW; Sirotnak FM
Biochim Biophys Acta; 1975 Apr; 384(2):369-80. PubMed ID: 235997
[TBL] [Abstract][Full Text] [Related]
35. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
Chello PL; McQueen CA; DeAngelis LM; Bertino JR
Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological activity of folic acid and methotrexate analogues containing L-threo-(2S,4S)-4-fluoroglutamic acid and DL-3,3-difluoroglutamic acid.
Hart BP; Haile WH; Licato NJ; Bolanowska WE; McGuire JJ; Coward JK
J Med Chem; 1996 Jan; 39(1):56-65. PubMed ID: 8568827
[TBL] [Abstract][Full Text] [Related]
37. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
[TBL] [Abstract][Full Text] [Related]
38. 2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes.
Piras S; Carta A; Briguglio I; Corona P; Paglietti G; Luciani R; Costi MP; Ferrari S
Eur J Med Chem; 2014 Mar; 75():169-83. PubMed ID: 24531230
[TBL] [Abstract][Full Text] [Related]
39. Quinazoline antifolate thymidylate synthase inhibitors: benzoyl ring modifications in the C2-methyl series.
Marsham PR; Jackman AL; Oldfield J; Hughes LR; Thornton TJ; Bisset GM; O'Connor BM; Bishop JA; Calvert AH
J Med Chem; 1990 Nov; 33(11):3072-8. PubMed ID: 2231608
[TBL] [Abstract][Full Text] [Related]
40. Dual inhibitors of thymidylate synthase and dihydrofolate reductase as antitumor agents: design, synthesis, and biological evaluation of classical and nonclassical pyrrolo[2,3-d]pyrimidine antifolates(1).
Gangjee A; Jain HD; Phan J; Lin X; Song X; McGuire JJ; Kisliuk RL
J Med Chem; 2006 Feb; 49(3):1055-65. PubMed ID: 16451071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
